AUTHOREA
Log in Sign Up Browse Preprints

July 16, 2020
The potential role of Gliptins to fight COVID-19
Francesco Ferrara and Antonio Vitiello
July 16, 2020
The clinical rationale of Sacubitril/valsartan for therapeutic treatment in Sars-CoV-...
Francesco Ferrara and Antonio Vitiello
June 24, 2020
Sacubitril/Valsartan and SARS-CoV-2
Antonio Vitiello, Raffaele La Porta, Francesco Ferrara, et al.
May 26, 2020
Colchicine and SARS-CoV-2 prospects for clinical management of the inflammatory state
Antonio Vitiello and Francesco Ferrara
May 26, 2020
The impact of COVID-19 in diabetic patient
Antonio Vitiello and Francesco Ferrara
May 11, 2020
Are multiple sclerosis therapies safe in SARS-Cov-2 times?
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, et al.
May 13, 2020
Active agents of Renin Angiotensin System and SARS-CoV-2
Antonio Vitiello, Raffaele La Porta, Giovanni Granata, et al.
May 11, 2020
Plasma Therapy in the fight against Sars-CoV-2: what boils in the pot.
Antonio Vitiello, Francesco Ferrara, Raffaele La Porta, et al.
May 07, 2020
A shift to avoid Covid-19 risk and safeguard health governance
Francesco Ferrara and Antonio Vitiello
May 06, 2020
Clinical and phamacological analysis of Sars Cov 2: how combination therapy makes che...
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, et al.
April 29, 2020
Clinical pharmacology aspects in patients treated with TNF inhibitors during SARS-Cov...
Antonio Vitiello, Chiara Pelliccia, Francesco Ferrara, et al.
April 27, 2020
The added value of pirfenidone to declare war on inflammation and the fibrotic state...
Francesco Ferrara, Giovanni Granata, Chiara Pelliccia, et al.